Skip to main content

Table 2 Radiological characteristics of the ‘baseline cohort’ by anticoagulation scheme

From: Association of oral anticoagulants with risk of brain haemorrhage expansion compared to no-anticoagulation

 

DOAC (N = 577)

VKA (N = 251)

Non-OAC (N = 123)

p values

Variable

N

Value

N

Value

N

Value

DOAC vs. non-OAC

VKA vs. non-OAC

Onset to first brain imaging‡, hours, median (IQR)

532

2 (1–6)

237

2 (1–6)

109

3 (1–7)

0.087

0.444

Baseline haematoma volume, mL, median (IQR)

556

13 (4–38)

247

11 (5–43)

120

10 (3–30)

0.344

0.220

Ventricular extension, n (%)

577

252 (43.7)

251

115 (45.8)

123

45 (36.6)

0.149

0.090

Surgical treatment, n (%)

  Haematoma evacuation

577

26 (4.5)

251

16 (6.4)

123

4 (3.3)

0.533

0.207

  Ventricular drainage

577

51 (8.8)

251

29 (11.6)

123

9 (7.3)

0.584

0.203

  1. DOAC, direct oral anticoagulant; No-OAC, no oral anticoagulation; VKA, vitamin K antagonists
  2. Onset: symptom onset, in case of unknown onset, last-seen-well